Your cart is currently empty.
- Your Giving to the Myeloma Crowd Research Initiative Reaps Cozy Rewards – Free Gift with Donation Now Until December 31!
- Considerations on Cost and Convenience of Multiple Myeloma Therapy
- Our Next Show: ASCO and EHA Myeloma Meeting Updates with Sagar Lonial, MD, Winship Cancer Institute, Wednesday, July 19 @ 2 pm Eastern
- FDA Panel Recommends Approval for Novartis CAR T Cell Treatment in Leukemia
- Gaining INSIGHT into Myeloma Treatment Effectiveness
- Hope vs. Hype in New Cancer Therapies
- Clinical Trial: For Patients Resistant to Lenalidomide, the Antibody Elotuzumab With the Newer Pomalidomide and Dex for Relapsed/Refractory Myeloma
- Second Study Shows Kyprolis® Improves Overall Survival for Relapsed/Refractory Myeloma
- Patient Power: Progress in Immunotherapies and Precision Medicine